[ TearClear raises $4.5M in Series A ]
TearClear has raised $4.5 million in Series A funding.
Founded in 2015, TearClear is an eye health technology company uniquely focused on developing a safe and reliable means of delivering preservative-free topical ophthalmic drugs.
The financing will provide sufficient capital to advance development of TearClear’s filter technology, the first and only system to assure the safe delivery of a preservative-free drop from preserved, multi-dose products.
|City||Orange County, California|
|Founder / CEO||Kevin Hershfield|
|Visionary Venture Fund|